Alto Neuroscience (ANRO) Cash from Investing Activities (2023 - 2026)

Alto Neuroscience has reported Cash from Investing Activities for 4 years, with the latest figure at -$556000.0 in Q1 2026.

• Quarterly Cash from Investing Activities fell 2216.67% year-over-year to -$556000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$556000.0 (up 70.35% YoY) and the FY2025 annual result came in at -$24000.0, up 98.84% from the prior year.
• Cash from Investing Activities retreated to -$556000.0 in Q1 2026 per ANRO's latest filing, from -$24000.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$21000.0 in Q1 2023 and troughed at -$1.0 million in Q3 2024.
• A 4-year average of -$312500.0 and a median of -$282000.0 in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities plunged 2237.21% in 2024, then jumped 89.29% in 2025.
• Over 4 years, Cash from Investing Activities stood at -$352000.0 in 2023, then sank by 43.75% to -$506000.0 in 2024, then surged by 95.26% to -$24000.0 in 2025, then sank by 2216.67% to -$556000.0 in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$556000.0, -$24000.0, and -$506000.0 for Q1 2026, Q1 2025, and Q4 2024 respectively.